Compounds > methylprednisolone

methylprednisolone and topiramate

methylprednisolone has been researched along with topiramate in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (27.27)29.6817
2010's8 (72.73)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Campillo, NE; Guerra, A; Páez, JA1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Nipper, KS; Ramos-Esteban, JC; Rhee, DJ1
Giede-Jeppe, A; Maihöfner, C; Speck, V; Sperling, W1
Degirmenci, Y; Kececi, H1
Lam, L; Merriman, M; Ormonde, S; Wang, N1

Reviews

1 review(s) available for methylprednisolone and topiramate

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

10 other study(ies) available for methylprednisolone and topiramate

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol.
    American journal of ophthalmology, 2006, Volume: 141, Issue:6

    Topics: Adult; Anterior Eye Segment; Diuretics, Osmotic; Drug Therapy, Combination; Female; Fructose; Glaucoma, Angle-Closure; Glucocorticoids; Humans; Intraocular Pressure; Mannitol; Methylprednisolone; Microscopy, Acoustic; Topiramate; Visual Acuity

2006
Complete remission of SUNCT syndrome by intravenous glucocorticoid treatment.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2013, Volume: 34, Issue:10

    Topics: Administration, Intravenous; Aged; Female; Fructose; Glucocorticoids; Humans; Methylprednisolone; Neuroprotective Agents; SUNCT Syndrome; Topiramate

2013
Topiramate response in adult-onset opsoclonus-myoclonus-ataxia syndrome: A case report.
    Revue neurologique, 2017, Volume: 173, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Ataxia; Fructose; Humans; Male; Methylprednisolone; Neuroprotective Agents; Opsoclonus-Myoclonus Syndrome; Positron-Emission Tomography; Recovery of Function; Topiramate; Treatment Outcome

2017
Topiramate-induced secondary angle closure: salient points in management.
    Clinical & experimental optometry, 2018, Volume: 101, Issue:5

    Topics: Adult; Anticonvulsants; Female; Glaucoma, Angle-Closure; Glucocorticoids; Gonioscopy; Humans; Infusions, Intravenous; Intraocular Pressure; Male; Methylprednisolone; Middle Aged; Topiramate; Trabecular Meshwork

2018